← Back to Search

Prosperando: Fostering Resilience on Dialysis

N/A

Waitlist Available

Research Sponsored by Denver Health and Hospital Authority

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed twice: at time of enrollment and at time of study completion (up to 1 year)

Summary

This trial will assess the feasibility of a 1-arm intervention of a 5-visit lay Peer Navigator intervention to support Latino ESRD patients with social challenges and adherence.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed twice: at time of enrollment and at time of study completion (up to 1 year)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed twice: at time of enrollment and at time of study completion (up to 1 year)

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed twice: at time of enrollment and at time of study completion (up to 1 year) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Interdialytic weight gain

Secondary study objectives

Albumin

Emergency Department visits and hospitalizations

Hemodialysis adherence

+10 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: peer navigatorActive Control1 Intervention

The first PN visit will take place within 1-2 weeks of consent. Each of the 5 subsequent PN visits will take place every 1-2 weeks. We expect patients to complete the intervention within 2-3 months of consent. The function of the initial visit is to establish trust and ensure a more personal approach with participants. The community-based PN intervention is grounded in core Latino values (e.g. trust, personalized relationships). The core elements of the PN intervention include patient motivational interviewing as well as patient activation, empowerment (e.g. help with scheduling of healthcare appointments and re-scheduling of missed HD sessions), education (e.g. education of ESKD and need for renal replacement therapy), and social challenges (e.g. access to resources for transportation, benefits, immigration issues). The duration, individuals present during the visit, and content discussed will be documented in the visit form.

Group II: Control Arm (standard of care)Placebo Group1 Intervention

Standard of care

Do I qualify?Apply below to find out